Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion type Assertion NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_head.
- NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_provenance.
- NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion evidence source_evidence_literature NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_provenance.
- NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion SIO_000772 16951139 NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_provenance.
- NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion wasDerivedFrom befree-2016 NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_provenance.
- NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion wasGeneratedBy ECO_0000203 NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_provenance.